Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine

Clarke, S C and Edwards, G F (2000) Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine. Scottish Medical Journal, 45 (3), 67. (doi:10.1177/003693300004500301).

Abstract

Meningococcal disease (MD) continues to have a major public health impact in Scotland and elsewhere. The incidence of confirmed disease has continued to increase at a time of raised public and medical awareness and improved
laboratory techniques. In Scotland, Neisseria meningitidis serogroup C has been the most common cause of disease over the past few years, accounting for 46% of confirmed cases in 1998, against 43% serogroup B. The serogroup distribution differs slightly to that in England and Wales in that serogroup
B has been most common there in past years.

Recently, however, the UK commenced the introduction of the MenC vaccination campaign which initially targeted babies aged 2-4 months and teenagers between 15 and 17 years; other age groups will follow when vaccine becomes available.' In the months since the introduction of the vaccine there has been a
decrease in the number of group C cases but an overall increase in total cases.

This record has no associated files available for download.

Contributors

Author: S C Clarke

Download statistics